About us

The Australian Dementia Network (ADNeT) is the largest single research program funded to date through the NHMRC’s $200 million Boosting Dementia Research Initiative. An additional $2 million has been dedicated by philanthropic organisations The Wicking Trust and The Yulgilbar Foundation.

Dementia is Australia’s second leading cause of death. Without a medical breakthrough, the number of Australians with a dementia diagnosis is expected to increase to more than 530,000 by 2025 and over 1.1 million by 2056.  The sector faces additional challenges including service fragmentation and the lack of unified standards to improve dementia diagnosis and care in Australia.

To address these significant challenges, ADNeT is bringing together Australia’s top researchers to drive ongoing, high-quality research and clinical care for Australians living with, or at risk of, cognitive impairment and dementia.

A sustainable, translational research infrastructure is being created to support these ambitious goals by:

  • Establishing an integrated network of dementia researchers, clinicians, service providers, industry and consumers.
  • Developing and maintaining a clinical quality registry (CQR) that can track, benchmark and report on the quality of clinical care of people with dementia and mild cognitive impairment. The register will drive quality improvements, quickly identify patients for clinical trials and systematically collect longitudinal data for research on the determinants, epidemiology and trajectory of cognitive decline.
  • Establishing a national network of Memory Clinics to optimise the assessment of cognitive disorders and improve specialist access for all Australians.
  • Developing a large, highly-characterised cohort of people with dementia, or at increased risk of dementia, for participation in cutting-edge clinical trials and to study the natural history of dementia.
  • Connecting with existing infrastructure supporting clinical trials in Australia to enhance the capacity for state-of-the-art assessments and the conduct of clinical trials nationally.
  • Integrating Australian research with the international effort to prevent or effectively treat dementia.

ADNeT committee members meet in Melbourne on Wednesday, May 8, 2019.

ADNeT is bringing together Australia's top researchers to drive ongoing, high-quality research and clinical care for Australians living with, or at risk of, cognitive impairment and dementia.

Led by Professor Chris Rowe, ADNeT comprises 25 investigators across 12 institutions and a broad spectrum of government, clinicians and consumer advisors.

ADNeT is supported by the NHMRC National Institute for Dementia Research, The Wicking Trust, The Yulgilbar Foundation, Dementia Australia and Austin Health.

Partner institutions are drawn from across Australia and include the University of Melbourne, University of New South Wales, Monash University, Edith Cowan University, CSIRO,  Flinders University, SAHMRI, University of  Sydney, NeuRA, Macquarie University,  QIMR Berghofer, and the University of Tasmania.